TAOX GoodMoat Verdict
Full signal breakdown coming soon. Use the X-Ray tool for a detailed analysis.
TAO Synergies Inc
Exchange: NASDAQSector: HealthcareIndustry: Biotechnology
TAO Synergies Inc. is the first pure-play public company dedicated to the intersection of cryptocurrency and AI, with a treasury strategy centered on acquiring, staking, and leveraging Bittensor (TAO) tokens. By providing transparent, regulated exposure to decentralized AI, TAO Synergies empowers investors to participate in the next era of technological disruption.
Did you know?
Price sits at 39% of its 52-week range.
Current Price
$5.33
+3.90%Profile
Valuation (TTM)
Market Cap$38.00M
P/E-1.30
EV—
P/B1.80
Shares Out7.13M
P/Sales127.05
Revenue$299061.00
EV/EBITDA—
TAO Synergies Inc (TAOX) Quality Analysis
TAOX Profitability
Profitability trend analysis coming soon
TAOX Growth
Growth trend analysis coming soon
TAOX Financial Health
Financial health indicators coming soon
TAOX Quality & Fundamental Analysis
TAO Synergies Inc (TAOX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ. This quality analysis page evaluates TAO Synergies Inc's financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.
TAO Synergies Inc has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency. The company operates with a profit margin of -9609.23% and a return on equity (ROE) of -136.51%. Return on assets (ROA) stands at -111.23%.
with a current ratio of 13.99. Operating margin is -3025.19%.
GoodMoat's quality analysis uses AI-powered insights to evaluate whether TAO Synergies Inc is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.